remdesivir

remdesivir

FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (Covid-19), during the outbreak of the coronavirus disease (Covid-19), in Oceanside, California, US, April 29, 2020. REUTERS/Mike Blake/File Photo

Gilead files US marketing application for remdesivir

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Canada gives conditional approval to Gilead's remdesivir for Covid-19

Remdesivir saved the day for pharma industry

Remdesivir saved the day for pharma industry

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Indian police arrest 14 for black market remdesivir as Covid-19 cases jump

Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Gilead Sciences Inc/Handout via Reuters

One in three South Korean Covid-19 patients improve with remdesivir

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Australia approves remdesivir as coronavirus treatment

Photo: Collected.

EU looking to ramp-up production of Covid-19 antiviral remdesivir

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

EU grants conditional clearance to Covid-19 antiviral remdesivir

Photo: Collected.

US buys up world stock of key Covid-19 drug remdesivir

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Gilead prices Covid-19 drug candidate remdesivir at $2,340 per patient

FILE PHOTO: People wear masks to avoid the spread of the coronavirus disease (COVID-19) at a department store in Seoul, South Korea April 30, 2020. REUTERS/Kim Hong-Ji

South Korea backs remdesivir for Covid-19, urges caution with dexamethasone

Photo: Collected.

Gilead's remdesivir set to become Europe's first Covid-19 therapy

An ampule of Ebola drug remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (Covid-19) continues/ Reuters

Gilead to test inhaled version of remdesivir on Covid-19 patients in August